Phase II/III Trial of Temozolomide With or Without Veliparib in Glioblastoma Multiforme
This trial is evaluating the efficacy of temozolomide combined with veliparib versus temozolomide alone in glioblastoma patients.
Therapeutic Area
Therapeutic area intelligence for Glioblastoma with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.